Publication | Closed Access

The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial

ObesityNutritionMetabolic SyndromeNigella Sativa SupplementationHepatologyCardiovascular DiseaseCardiometabolic RiskNon-alcoholic Fatty LiverLiver PhysiologyPharmacologyRandomized Double-blindCardiometabolic NutritionLiver DiseaseFatty Liver DiseaseMedicineAnesthesiologyHealth Sciences